About MindImmune
MindImmune is a private company based in Kingston, Rhode Island. It has reported $21,318,342 raised in three offerings on Form D since November 2019. Its chief executive is Isaac Stoner.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | Dec 5, 2025amended Mar 5, 2026 | $15,218,343of $17.0M target | 15 | $1.0M | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 25, 2022 | Feb 4, 2022 | $5,349,999of $8.8M target | 12 | $445K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 22, 2019 | Nov 1, 2019 | $750,000of $3.0M target | 8 | $93,750 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $21,318,342 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MindImmune's Form D filed Mar 5, 2026.
Earlier filings also listed Tracy Saxton (director, last listed Feb 2022), Stevin Zorn (president and director, last listed Feb 2022), Robert Nelson (executive officer, last listed Feb 2022), Diane Gooding (executive officer, last listed Feb 2022), Richard Horan (director, last listed Nov 2019) and Frank Menniti (executive officer and director, last listed Nov 2019).